Duško M Dundjerović

7PUBLICATIONS
27CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursBiomolecular modelling and designTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2025
ETS1 Protein Expression May Be Altered by the Complementarity of ETS1 mRNA Sequences with miR-203a-3p and miR-204-3p in Papillary Thyroid Carcinoma.

Stefana Stojanović Novković, Sonja Šelemetjev, Jelena Janković Miljuš

|Nov 15, 2024
The impact of 9-azaglycophymine and phenylguanidine derivatives on the proliferation of various breast cancer cell lines in vitro and in vivo.

Ibrahim Morgan, Robert Rennert, Robert Berger

|Apr 26, 2024
Comprehensive Investigation of Angiogenesis, PASS Score and Immunohistochemical Factors in Risk Assessment of Malignancy for Paraganglioma and Pheochromocytoma.

Marija Milinkovic, Ivan Soldatovic, Vladan Zivaljevic

|Apr 25, 2024
Novel triphenyltin(IV) compounds with carboxylato <i>N</i>-functionalized 2-quinolones as promising potential anticancer drug candidates: <i>in vitro</i> and <i>in vivo</i> evaluation.

Marijana P Kasalović, Sanja Jelača, Žiko Milanović

|Mar 28, 2024
Dual Role of <i>Alchemilla vulgaris</i> L. Extract in Breast Cancer Regression: Reestablishment of Effective Immune Response.

Sanja Jelača, Ivan Jovanovic, Dijana Bovan

|Nov 11, 2022
Mesoporous Silica Nanoparticles Enhance the Anticancer Efficacy of Platinum(IV)-Phenolate Conjugates in Breast Cancer Cell Lines.

Ivana Predarska, Mohamad Saoud, Dijana Drača

Pageof 2

Frequent Collaborators

3 joint publications

Danijela Maksimović-Ivanić

3 joint publications

Goran N Kaluđerović

3 joint publications

Sanja Jelača

2 joint publications

Ibrahim Morgan